Granahan Investment Management’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Granahan Investment Management's CLBT Position: Q2 2026 in Review
Granahan Investment Management reduced its Cellebrite (CLBT) stake by 4.5% in Q2 2026, selling an estimated $1.04M and leaving 1,661,163 shares worth $24.3M. The position accounts for 0.86% of the portfolio, ranked #31.
Granahan Investment Management first reported a position in CLBT in Q1 2024 and has held it in 10 quarters since. The position peaked at $55.1M in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Granahan Investment Management held 1,661,163 shares of Cellebrite worth $24.3M as of Q2 2026.
- Granahan Investment Management sold 78,481 Cellebrite shares in Q2 2026, an estimated $1.04M.
- Cellebrite made up 0.86% of Granahan Investment Management's portfolio in Q2 2026, its #31 holding.
- Granahan Investment Management first reported a position in Cellebrite in Q1 2024 and has held it in 10 quarters since.
- Granahan Investment Management's Cellebrite position peaked at $55.1M in Q4 2025.
- 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Granahan Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.